Cargando…
Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone
Mitoxantrone, an FDA-approved therapeutic for the treatment of cancer and multiple sclerosis, was previously reported to exhibit antiviral activity against vaccinia virus. To determine whether this activity extends to other orthopoxviruses, mitoxantrone was tested against cowpox and monkeypox. Mitox...
Autores principales: | Altmann, Sharon E., Smith, Alvin L., Dyall, Julie, Johnson, Reed F., Dodd, Lori E., Jahrling, Peter B., Paragas, Jason, Blaney, Joseph E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272698/ https://www.ncbi.nlm.nih.gov/pubmed/22182595 http://dx.doi.org/10.1016/j.antiviral.2011.12.001 |
Ejemplares similares
-
Poxvirus Antigen Staining of Immune Cells as a Biomarker to Predict Disease Outcome in Monkeypox and Cowpox Virus Infection in Non-Human Primates
por: Song, Haifeng, et al.
Publicado: (2013) -
The effect of volume of interest definition on quantification of lymph node immune response to a monkeypox virus infection assessed by (18)F-FDG-PET
por: Chefer, Svetlana, et al.
Publicado: (2014) -
Viremia in human Cowpox virus infection
por: Nitsche, Andreas, et al.
Publicado: (2007) -
Systems Kinomics Demonstrates Congo Basin Monkeypox Virus Infection Selectively Modulates Host Cell Signaling Responses as Compared to West African Monkeypox Virus
por: Kindrachuk, Jason, et al.
Publicado: (2012) -
Antiviral activity of the EB peptide against zoonotic poxviruses
por: Altmann, Sharon E, et al.
Publicado: (2012)